
FOLLOWUS
Department of Radiology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
*E-mail: terrytang78@163.com
收稿日期:2021-08-19,
录用日期:2021-9-14,
网络出版日期:2021-09-21,
纸质出版日期:2021-09-21
Scan QR Code
李佳铮, 唐磊. 影像组学在抗肿瘤药物临床试验疗效评估中的应用和挑战[J]. 中国医学科学杂志(英文版), 2021,36(3):187-195.
Li Jiazheng, Tang Lei. Radiomics in Antineoplastic Agents Development: Application and Challenge in Response Evaluation[J]. Chinese medical sciences journal, 2021, 36(3): 187-195.
李佳铮, 唐磊. 影像组学在抗肿瘤药物临床试验疗效评估中的应用和挑战[J]. 中国医学科学杂志(英文版), 2021,36(3):187-195. DOI: 10.24920/003985.
Li Jiazheng, Tang Lei. Radiomics in Antineoplastic Agents Development: Application and Challenge in Response Evaluation[J]. Chinese medical sciences journal, 2021, 36(3): 187-195. DOI: 10.24920/003985.
抗肿瘤药物的快速发展改善了恶性肿瘤患者预后。以CT、MRI和PET为代表的影像学手段作为重要的终点替代指标
在新药临床试验中发挥着越来越重要的作用。但因抗肿瘤药物作用靶点、应用线数等不同
治疗后影像学征象变化的个体差异较大
单用RECIST标准已无法满足个体化精准评效的需求。影像组学作为一种依托于新兴计算机技术的特征提取和模型构建手段
有望协助临床进行抗肿瘤药物治疗疗效的精准评估。本文介绍了影像组学的基本概念
回顾了影像组学在抗肿瘤药物疗效评价方面的最新进展
深入分析影像组学在预测肿瘤分子标志物、评价治疗疗效和预后预测方面的应用潜力
探讨了目前影像组学在抗肿瘤药物临床研究中存在的主要问题和未来发展方向。
The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice. Radiological methods including CT
MRI and PET play an increasingly important role in evaluating the efficacy of these antineoplastic drugs. However
different antineoplastic agents potentially induce different radiological signs
making it a challenge for radiological response evaluation
which depends mainly on one-sided morphological response evaluation criteria in solid tumors (RECIST) in the status quo of clinical practice. This brings opportunities for the development of radiomics
which is promising to serve as a surrogate for response evaluations of anti-tumor treatments. In this article
we introduce the basic concepts of radiomics
review the state-of-art radiomics researches with highlights of radiomics application in predictions of molecular biomarkers
treatment response
and prognosis. We also provide in-depth analyses on major obstacles and future direction of this new technique in clinical investigations on new antineoplastic agents.
Smith BD , Kaufman MD , Lu WP , et al . Ripretinib (DCC-2618) is a switch control kinase inhibitor of a broad spectrum of oncogenic and drug-resistantKIT and PDGFRA variants . Cancer Cell 2019 ; 35 ( 5 ): 738 - 51.e9 . doi: 10.1016/j.ccell.2019.04.006 1001-9294-36-3-187/j.ccell.2019.04.006 . DOI: 10.1016/j.ccell.2019.04.006 http://doi.org/10.1016/j.ccell.2019.04.006 https://linkinghub.elsevier.com/retrieve/pii/S1535610819302016 https://linkinghub.elsevier.com/retrieve/pii/S1535610819302016
Zhang X , Liang H , Li Z , et al . Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial . Lancet Oncol 2021 ; 22 ( 8 ): 1081 - 92 . doi: 10.1016/S1470-2045(21)00297-7 1001-9294-36-3-187/S1470-2045(21)00297-7 . DOI: 10.1016/S1470-2045(21)00297-7 http://doi.org/10.1016/S1470-2045(21)00297-7 https://linkinghub.elsevier.com/retrieve/pii/S1470204521002977 https://linkinghub.elsevier.com/retrieve/pii/S1470204521002977
Gong J , Chehrazi-Raffle A , Reddi S , et al . Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations . J Immunother Cancer 2018 ; 6 ( 1 ): 8 . doi: 10.1186/s40425-018-0316-z 1001-9294-36-3-187/s40425-018-0316-z . DOI: 10.1186/s40425-018-0316-z http://doi.org/10.1186/s40425-018-0316-z
The Center for Drug Evaluation , National Medical Products Administration, China . The principles and procedures of clinical trial imaging endpoint process standards for antineoplastic agents . Available from: https://www.cde.org.cn/main/att/download/cebb08a90ca9af65d0bf1fa06235039e. Released January 14, 2021 ; accessed August 15, 2021. https://www.cde.org.cn/main/att/download/cebb08a90ca9af65d0bf1fa06235039e https://www.cde.org.cn/main/att/download/cebb08a90ca9af65d0bf1fa06235039e
Choi H , Charnsangavej C , Faria SC , et al . Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria . J Clin Oncol 2007 ; 25 ( 13 ): 1753 - 9 . doi: 10.1200/JCO.2006.07.3049 1001-9294-36-3-187/JCO.2006.07.3049 . DOI: 10.1200/JCO.2006.07.3049 http://doi.org/10.1200/JCO.2006.07.3049 http://ascopubs.org/doi/10.1200/JCO.2006.07.3049 http://ascopubs.org/doi/10.1200/JCO.2006.07.3049
Bi WL , Hosny A , Schabath MB , et al . Artificial intelligence in cancer imaging: Clinical challenges and applications . CA Cancer J Clin 2019 ; 69 ( 2 ): 127 - 57 . doi: 10.3322/caac.21552 1001-9294-36-3-187/caac.21552 . DOI: 10.3322/caac.21552 http://doi.org/10.3322/caac.21552
Gillies RJ , Kinahan PE , Hricak H . Radiomics: images are more than pictures, they are data . Radiology 2016 ; 278 ( 2 ): 563 - 77 . doi: 10.1148/radiol.2015151169 1001-9294-36-3-187/radiol.2015151169 . DOI: 10.1148/radiol.2015151169 http://doi.org/10.1148/radiol.2015151169
Erickson BJ , Korfiatis P , Akkus Z , et al . Machine learning for medical imaging . Radiographics 2017 ; 37 ( 2 ): 505 - 5 . doi: 10.1148/rg.2017160130 1001-9294-36-3-187/rg.2017160130 . DOI: 10.1148/rg.2017160130 http://doi.org/10.1148/rg.2017160130
Li Y , Cheng Z , Gevaert O , et al . A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer . Chin J Cancer Res 2020 ; 32 ( 1 ): 62 - 71 . doi: 10.21147/j.issn.1000-9604.2020.01.08 1001-9294-36-3-187/j.issn.1000-9604.2020.01.08 . DOI: 10.21147/j.issn.1000-9604.2020.01.08 http://doi.org/10.21147/j.issn.1000-9604.2020.01.08 http://article.cjcrcn.org/en/article/doi/10.21147/j.issn.1000-9604.2020.01.08?viewType=HTML http://article.cjcrcn.org/en/article/doi/10.21147/j.issn.1000-9604.2020.01.08?viewType=HTML
Esteva A , Robicquet A , Ramsundar B , et al . A guide to deep learning in healthcare . Nat Med 2019 ; 25 ( 1 ): 24 - 9 . doi: 10.1038/s41591-018-0316-z 1001-9294-36-3-187/s41591-018-0316-z . DOI: 10.1038/s41591-018-0316-z http://doi.org/10.1038/s41591-018-0316-z
LeCun Y , Bengio Y , Hinton G . Deep learning . Nature 2015 ; 521 ( 7553 ): 436 - 44 . doi: 10.1038/nature14539 1001-9294-36-3-187/nature14539 . DOI: 10.1038/nature14539 http://doi.org/10.1038/nature14539 https://doi.org/10.1038/nature14539 https://doi.org/10.1038/nature14539
Hosny A , Parmar C , Quackenbush J , et al . Artificial intelligence in radiology . Nat Rev Cancer 2018 ; 18 ( 8 ): 500 - 10 . doi: 10.1038/s41568-018-0016-5 1001-9294-36-3-187/s41568-018-0016-5 . DOI: 10.1038/s41568-018-0016-5 http://doi.org/10.1038/s41568-018-0016-5 https://doi.org/10.1038/s41568-018-0016-5 https://doi.org/10.1038/s41568-018-0016-5
Lee IS , Park YS , Lee JH , et al . Pathologic discordance of differentiation between endoscopic biopsy and postoperative specimen in mucosal gastric adenocarcinomas . Ann Surg Oncol 2013 ; 20 ( 13 ): 4231 - 7 . doi: 10.1245/s10434-013-3196-y 1001-9294-36-3-187/s10434-013-3196-y . DOI: 10.1245/s10434-013-3196-y http://doi.org/10.1245/s10434-013-3196-y http://link.springer.com/10.1245/s10434-013-3196-y http://link.springer.com/10.1245/s10434-013-3196-y
Xu F , Ma X , Wang Y , et al . CT texture analysis can be a potential tool to differentiate gastrointestinal stromal tumors without KIT exon 11 mutation . Eur J Radiol 2018 ; 107 : 90 - 7 . doi: 10.1016/j.ejrad.2018.07.025 1001-9294-36-3-187/j.ejrad.2018.07.025 . DOI: 10.1016/j.ejrad.2018.07.025 http://doi.org/10.1016/j.ejrad.2018.07.025 https://linkinghub.elsevier.com/retrieve/pii/S0720048X18302614 https://linkinghub.elsevier.com/retrieve/pii/S0720048X18302614
Sun R , Limkin EJ , Vakalopoulou M , et al . A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study . Lancet Oncol 2018 ; 19 ( 9 ): 1180 - 91 . doi: 10.1016/S1470-2045(18)30413-3 1001-9294-36-3-187/S1470-2045(18)30413-3 . DOI: 10.1016/S1470-2045(18)30413-3 http://doi.org/10.1016/S1470-2045(18)30413-3 https://linkinghub.elsevier.com/retrieve/pii/S1470204518304133 https://linkinghub.elsevier.com/retrieve/pii/S1470204518304133
Jiang Y , Wang H , Wu J , et al . Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer . Ann Oncol 2020 ; 31 ( 6 ): 760 - 8 . doi: 10.1016/j.annonc.2020.03.295 1001-9294-36-3-187/j.annonc.2020.03.295 . DOI: 10.1016/j.annonc.2020.03.295 http://doi.org/10.1016/j.annonc.2020.03.295 https://linkinghub.elsevier.com/retrieve/pii/S0923753420363821 https://linkinghub.elsevier.com/retrieve/pii/S0923753420363821
Jiang Y , Liang X , Han Z , et al . Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study . Lancet Digit Health 2021 ; 3 ( 6 ): e371 - e382 . doi: 10.1016/S2589-7500(21)00065-0 1001-9294-36-3-187/S2589-7500(21)00065-0 . DOI: 10.1016/S2589-7500(21)00065-0 http://doi.org/10.1016/S2589-7500(21)00065-0
Mu W , Jiang L , Zhang J , et al . Non-invasive decision support for NSCLC treatment using PET/CT radiomics . Nat Commun 2020 ; 11 ( 1 ): 5228 . doi: 10.1038/s41467-020-19116-x 1001-9294-36-3-187/s41467-020-19116-x . DOI: 10.1038/s41467-020-19116-x http://doi.org/10.1038/s41467-020-19116-x https://doi.org/10.1038/s41467-020-19116-x https://doi.org/10.1038/s41467-020-19116-x
Rossi G , Barabino E , Fedeli A , et al . Radiomic detection of EGFR mutations in NSCLC . Cancer Res 2021 ; 81 ( 3 ): 724 - 31 . doi: 10.1158/0008-5472.CAN-20-0999 1001-9294-36-3-187/0008-5472.CAN-20-0999 . DOI: 10.1158/0008-5472.CAN-20-0999 http://doi.org/10.1158/0008-5472.CAN-20-0999 http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-20-0999 http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-20-0999
Tian P , He B , Mu W , et al . Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images . Theranostics 2021 ; 11 ( 5 ): 2098 - 107 . doi: 10.7150/thno.48027 1001-9294-36-3-187/thno.48027 . DOI: 10.7150/thno.48027 http://doi.org/10.7150/thno.48027 https://www.thno.org/v11p2098.htm https://www.thno.org/v11p2098.htm
Shi R , Chen W , Yang B , et al . Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features . Am J Cancer Res 2020 ; 10 ( 12 ): 4513 - 26 .
Trebeschi S , Drago SG , Birkbak NJ , et al . Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers . Ann Oncol 2019 ; 30 ( 6 ): 998 - 1004 . doi: 10.1093/annonc/mdz108 1001-9294-36-3-187/annonc/mdz108 . DOI: S0923-7534(19)31202-5 http://doi.org/S0923-7534(19)31202-5
Vaidya P , Bera K , Gupta A , et al . CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction . Lancet Digit Health 2020 ; 2 ( 3 ): e116 - e128 . doi: 10.1016/s2589-7500(20)30002-9 1001-9294-36-3-187/s2589-7500(20)30002-9 . DOI: 10.1016/s2589-7500(20)30002-9 http://doi.org/10.1016/s2589-7500(20)30002-9
Vaidya P , Bera K , Patil PD , et al . Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade . J Immunother Cancer 2020 ; 8 ( 2 ): e001343 . doi: 10.1136/jitc-2020-001343 1001-9294-36-3-187/jitc-2020-001343 . DOI: 10.1136/jitc-2020-001343 http://doi.org/10.1136/jitc-2020-001343 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2020-001343 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2020-001343
Dercle L , Lu L , Schwartz LH , et al . Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway . J Natl Cancer Inst 2020 ; 112 ( 9 ): 902 - 12 . doi: 10.1093/jnci/djaa017 1001-9294-36-3-187/jnci/djaa017 . DOI: 10.1093/jnci/djaa017 http://doi.org/10.1093/jnci/djaa017 https://academic.oup.com/jnci/article/112/9/902/5722208 https://academic.oup.com/jnci/article/112/9/902/5722208
Dercle L , Fronheiser M , Lu L , et al . Identification of non-small cell lung cancer sensitive to systemic cancer therapies using radiomics . Clin Cancer Res 2020 ; 26 ( 9 ): 2151 - 62 . doi: 10.1158/1078-0432.CCR-19-2942 1001-9294-36-3-187/1078-0432.CCR-19-2942 . DOI: 10.1158/1078-0432.CCR-19-2942 http://doi.org/10.1158/1078-0432.CCR-19-2942 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-19-2942 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-19-2942
Basler L , Gabryś HS , Hogan SA , et al . Radiomics, tumor volume, and blood biomarkers for early prediction of pseudoprogression in patients with metastatic melanoma treated with immune checkpoint inhibition . Clin Cancer Res 2020 ; 26 ( 16 ): 4414 - 25 . doi: 10.1158/1078-0432.CCR-20-0020 1001-9294-36-3-187/1078-0432.CCR-20-0020 . DOI: 10.1158/1078-0432.CCR-20-0020 http://doi.org/10.1158/1078-0432.CCR-20-0020
Xu Y , Hosny A , Zeleznik R , et al . Deep learning predicts lung cancer treatment response from serial medical imaging . Clin Cancer Res 2019 ; 25 ( 11 ): 3266 - 75 . doi: 10.1158/1078-0432.CCR-18-2495 1001-9294-36-3-187/1078-0432.CCR-18-2495 . DOI: 10.1158/1078-0432.CCR-18-2495 http://doi.org/10.1158/1078-0432.CCR-18-2495 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-18-2495 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-18-2495
Song J , Shi J , Dong D , et al . A new approach to predict progression-free survival in stage IV EGFR-mutant NSCLC patients with EGFR-TKI therapy . Clin Cancer Res 2018 ; 24 ( 15 ): 3583 - 92 . doi: 10.1158/1078-0432.CCR-17-2507 1001-9294-36-3-187/1078-0432.CCR-17-2507 . DOI: 10.1158/1078-0432.CCR-17-2507 http://doi.org/10.1158/1078-0432.CCR-17-2507 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-17-2507 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-17-2507
Song J , Wang L , Ng NN , et al . Development and validation of a machine learning model to explore tyrosine kinase inhibitor response in patients with stage IV EGFR variant-positive non-small cell lung cancer . JAMA Netw Open 2020 ; 3 ( 12 ): e2030442 . doi: 10.1001/jamanetworkopen.2020.30442 1001-9294-36-3-187/jamanetworkopen.2020.30442 . DOI: 10.1001/jamanetworkopen.2020.30442 http://doi.org/10.1001/jamanetworkopen.2020.30442 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774288 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774288
Zhang N , Liang R , Gensheimer MF , et al . Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer . Theranostics 2020 ; 10 ( 25 ): 11707 - 18 . doi: 10.7150/thno.50565 1001-9294-36-3-187/thno.50565 . DOI: 10.7150/thno.50565 http://doi.org/10.7150/thno.50565 https://www.thno.org/v10p11707.htm https://www.thno.org/v10p11707.htm
Jiang Y , Chen C , Xie J , et al . Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer . EBioMedicine 2018 ; 36 : 171 - 82 . doi: 10.1016/j.ebiom.2018.09.007 1001-9294-36-3-187/j.ebiom.2018.09.007 . DOI: 10.1016/j.ebiom.2018.09.007 http://doi.org/10.1016/j.ebiom.2018.09.007 https://linkinghub.elsevier.com/retrieve/pii/S2352396418303645 https://linkinghub.elsevier.com/retrieve/pii/S2352396418303645
Hudis CA . Trastuzumab--mechanism of action and use in clinical practice . N Engl J Med 2007 ; 357 ( 1 ): 39 - 51 . doi: 10.1056/NEJMra043186 1001-9294-36-3-187/NEJMra043186 . DOI: 10.1056/NEJMra043186 http://doi.org/10.1056/NEJMra043186 http://www.nejm.org/doi/abs/10.1056/NEJMra043186 http://www.nejm.org/doi/abs/10.1056/NEJMra043186
Li B , Jiang Y , Li G , et al . Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit . JCI Insight 2020 ; 5 ( 9 ): e136570 . doi: 10.1172/jci.insight.136570 1001-9294-36-3-187/jci.insight.136570 . DOI: 10.1172/jci.insight.136570 http://doi.org/10.1172/jci.insight.136570 https://insight.jci.org/articles/view/136570 https://insight.jci.org/articles/view/136570
Hegde PS , Karanikas V , Evers S . The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition . Clin Cancer Res 2016 ; 22 ( 8 ): 1865 - 74 . doi: 10.1158/1078-0432.CCR-15-1507 1001-9294-36-3-187/1078-0432.CCR-15-1507 . DOI: 10.1158/1078-0432.CCR-15-1507 http://doi.org/10.1158/1078-0432.CCR-15-1507 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-15-1507 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-15-1507
Nishino M , Hatabu H , Hodi FS . Imaging of cancer immunotherapy: current approaches and future directions . Radiology 2019 ; 290 ( 1 ): 9 - 22 . doi: 10.1148/radiol.2018181349 1001-9294-36-3-187/radiol.2018181349 . DOI: 10.1148/radiol.2018181349 http://doi.org/10.1148/radiol.2018181349
Park JE , Kim D , Kim HS , et al . Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement . Eur Radiol 2020 ; 30 ( 1 ): 523 - 36 . doi: 10.1007/s00330-019-06360-z 1001-9294-36-3-187/s00330-019-06360-z . DOI: 10.1007/s00330-019-06360-z http://doi.org/10.1007/s00330-019-06360-z
An C , Park YW , Ahn SS , et al . Radiomics machine learning study with a small sample size: Single random training-test set split may lead to unreliable results . PLoS One 2021 ; 16 ( 8 ): e0256152 . doi: 10.1371/journal.pone.0256152 1001-9294-36-3-187/journal.pone.0256152 . DOI: 10.1371/journal.pone.0256152 http://doi.org/10.1371/journal.pone.0256152 https://dx.plos.org/10.1371/journal.pone.0256152 https://dx.plos.org/10.1371/journal.pone.0256152
Wang Y , Jin ZY . Radiomics approaches in gastric cancer: a frontier in clinical decision making . Chin Med J (Engl) 2019 ; 132 ( 16 ): 1983 - 9 . doi: 10.1097/CM9.0000000000000360 1001-9294-36-3-187/CM9.0000000000000360 . DOI: 10.1097/CM9.0000000000000360 http://doi.org/10.1097/CM9.0000000000000360
Zhao B , Tan Y , Tsai WY , et al . Reproducibility of radiomics for deciphering tumor phenotype with imaging . Sci Rep 2016 ; 6 : 23428 . doi: 10.1038/srep23428 1001-9294-36-3-187/srep23428 . DOI: 10.1038/srep23428 http://doi.org/10.1038/srep23428 https://doi.org/10.1038/srep23428 https://doi.org/10.1038/srep23428
Rajkomar A , Dean J , Kohane I . Machine learning in medicine . N Engl J Med 2019 ; 380 ( 14 ): 1347 - 58 . doi: 10.1056/NEJMra1814259 1001-9294-36-3-187/NEJMra1814259 . DOI: 10.1056/NEJMra1814259 http://doi.org/10.1056/NEJMra1814259 http://www.nejm.org/doi/10.1056/NEJMra1814259 http://www.nejm.org/doi/10.1056/NEJMra1814259
Zhang Y , Li H , Du J , et al . 3D Multi-attention guided multi-task learning network for automatic gastric tumor segmentation and lymph node classification . IEEE Trans Med Imaging 2021 ; 40 ( 6 ): 1618 - 31 . doi: 10.1109/TMI.2021.3062902 1001-9294-36-3-187/TMI.2021.3062902 . DOI: 10.1109/TMI.2021.3062902 http://doi.org/10.1109/TMI.2021.3062902 https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=42 https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=42
Aganj I , Harisinghani MG , Weissleder R , et al . Unsupervised medical image segmentation based on the local center of mass . Sci Rep 2018 ; 8 ( 1 ): 13012 . doi: 10.1038/s41598-018-31333-5 1001-9294-36-3-187/s41598-018-31333-5 . DOI: 10.1038/s41598-018-31333-5 http://doi.org/10.1038/s41598-018-31333-5
Lambin P , Leijenaar RTH , Deist TM , et al . Radiomics: the bridge between medical imaging and personalized medicine . Nat Rev Clin Oncol 2017 ; 14 ( 12 ): 749 - 62 . doi: 10.1038/nrclinonc.2017.141 1001-9294-36-3-187/nrclinonc.2017.141 . DOI: 10.1038/nrclinonc.2017.141 http://doi.org/10.1038/nrclinonc.2017.141 http://www.nature.com/articles/nrclinonc.2017.141 http://www.nature.com/articles/nrclinonc.2017.141
Liu X , Cruz Rivera S , Moher D ; SPIRIT-AI and CONSORT-AI Working Group . Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension . Nat Med 2020 ; 26 ( 9 ): 1364 - 74 . doi: 10.1038/s41591-020-1034-x 1001-9294-36-3-187/s41591-020-1034-x . DOI: 10.1038/s41591-020-1034-x http://doi.org/10.1038/s41591-020-1034-x https://doi.org/10.1038/s41591-020-1034-x https://doi.org/10.1038/s41591-020-1034-x
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621